论文部分内容阅读
川崎病是常见于5岁以下儿童的全身中小血管炎症性疾病，也是目前儿童获得性心脏病最常见的诱因之一。干细胞是一类具有自我更新、自我复制、多向分化能力的多潜能细胞，是现代再生医学和组织工程的重要生物材料。截至目前，越来越多的研究发现，干细胞如内皮祖细胞、诱导多功能干细胞、脂肪源性干细胞等参与了川崎病发病机制的调控，并在其中发挥着抗炎和保护受损血管内皮细胞的重要作用。干细胞的潜能正逐渐被开发，并应用于川崎病诊疗。然而，目前干细胞在川崎病发病机制和治疗的作用机制尚未完全清楚，仍需要更多的基础实验和临床试验进行验证和完善。“,”Kawasaki disease is a systemic inflammatory disease of small and medium vessels in children under 5 years of age, which is also one of the most common causes of acquired heart disease in children.Stem cells are a kind of multipotential cells with the ability of self-renewal, self-replication and multi-differentiation.They are important biomaterials in modern regenerative medicine and tissue engineering.So far, substantial studies have found that stem cells such as endothelial progenitor cells, induced multifunctional stem cells, adipose-derived stem cells and so on are involved in the regulation of the pathogenesis of Kawasaki disease and play an important role in anti-inflammation and protection of the vascular endothelial cell damage.The potential of stem cells is gradually being developed and applied to the diagnosis and treatment of Kawasaki disease.However, the pathogenesis and treatment of stem cells in Kawasaki disease are not fully understood, and more basic and clinical trials are still needed.